StockData
MBX Biosciences, Inc. logo

MBX Biosciences, Inc. (MBX) stock

MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$53.10−0.02 (-0.04%)

Close on Nov 17, 2026Market cap $2.56BP/E –Yield –

MBX Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

MBX Biosciences's market cap was $2.77B on Nov 11, 2026, against $1.54B a year earlier. Over the last 2 years it ranged from $28.79M to $3.14B, with a median of $737.69M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.77B+96.2%
2025Dec 31, 2025$1.41B+129.3%
2024Dec 31, 2024$615.12M–

More MBX Biosciences figures

See a number that looks wrong?